Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-28
1997-08-19
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 514841, 514843, A61K 3803, A61K 3816, A61K 3817
Patent
active
056588763
ABSTRACT:
A method for contraception which features administering to a patient a contraceptive agent having activin-antagonist activity. The contraceptive agent results in inhibition of the activin-stimulated release of FSH, thereby resulting in a decrease in fertility and facilitating contraception in the patient.
REFERENCES:
patent: 4010256 (1977-03-01), Parlow
patent: 4552864 (1985-11-01), Antoni et al.
patent: 4740587 (1988-04-01), Ling et al.
patent: 4798885 (1989-01-01), Mason et al.
patent: 4864019 (1989-09-01), Vale et al.
patent: 5041538 (1991-08-01), Ling et al.
patent: 5196192 (1993-03-01), De Kretser et al.
patent: 5216126 (1993-06-01), Cox et al.
Alexander et al. "The Effects of Activin on Follicle-Stimulating Hormone Secretion and Biosynthesis in Human Glycoprotein Hormone-Producing Pituitary Adenomas" J. Clin. Endocrin. & Metab. 72:1261-1267 (1991).
Attardi et al. "Rapid Stimulatory Effect of Activin-A on Messenger RNA Encoding the Follicle-Stimulating Hormone .beta.-Subunit in Rat Pituitary Cell Cultures" Molec. Endocrin. 4:721-726 (1990).
Kogawa et al. "Activin-Binding Protein is Present in Pituitary" Endocrinology 128:1434-1440 (1991).
Sugino et al. "Molecular Multiplicity of Activin-Binding Protein/Follistatin from Porcine Ovary" The Endocrine Society Abstracts, p. 408, No. 1510 (1991).
Xiao et al. "Studies on the Mechanism of Activin and FSH Suppressing Protein in Cultured Rat Granulosa Cells" The Endocrie Society Abstracts, p. 370, No. 1359 (1991).
Campen et al., "Characterization of Activin A Binding Sites on the Human Leukemia Cell Line K562" Biochem & Biophys. Res. Comm., 157:844-849 (1988).
Centrella et al., "Activin-A Binding and Biochemical Effects in Osteoblast-Enriched Cultures from Fetal-Rat Parietal Bone" Molec. & Cellular Bio., 11:250-258 (1991).
Hemmati-Brivanlou et al., "A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos" Nature, 359:609-614 (1992).
Mason et al., "Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-.beta." Nature, 318:659-663 (1985).
Mason et al. "Structure of Two Human Ovarian Inhibins" Biochem. & Biophys. Comm., 135:957-964 (1986).
Corrigan et al., "Evidence for an Autocrine Role of Activin B within Rat Anterior Pituitary Cultures" Endocrinology, 128:1682-1684 (1991).
Weiss et al., "Dynamic Regulation of Follicle-Stimulating Hormone-.beta. Messenger Ribonucleic Acid Levels by Activin and Gonadotropin-Releasing Hormone in Perifused Rat . . . " Endocrinology, 131:1403-1408 (1992).
Weiss et al., "Perifusion of Rat Pituitary Cells with Gonadotropin-Releasing Hormone, Activin, and Inhibin Reveals Distinct Effects on Gonadotropin Gene Expression and Secretion" Endocrinology, 132:2307-2311 (1993).
Crowley William F.
Jameson J. Larry
Schneyer Alan L.
Weiss Jeffrey
Russel Jeffrey E.
The General Hospital Corporation
LandOfFree
Activin antagonists as novel contraceptives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activin antagonists as novel contraceptives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activin antagonists as novel contraceptives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1104761